Literature DB >> 18845485

Dendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma model.

Seagal Teitz-Tennenbaum1, Qiao Li, Mary A Davis, Alfred E Chang.   

Abstract

We compared viability, phenotype, in vitro function and therapeutic efficacy of murine unpulsed-dendritic cells (-DC), DC pulsed with keyhole limpet hemocyanin (KLH-DC) and cryopreserved KLH-DC (C-KLH-DC). Mean viability (%+/-SE) of unpulsed-DC, KLH-DC and C-KLH-DC was 93.6+/-0.9, 93.9+/-0.8 and 87.4+/-1.6, respectively. Pulsing DC with KLH did not induce maturation or affect in vitro function. Cryopreservation of KLH-DC reduced MHC I, CD80 and CD86 expression, endocytic capacity and allogeneic splenocyte stimulatory capacity. Intratumoral (i.t.) vaccination of mice bearing s.c. D5 melanoma with unpulsed-DC, KLH-DC or C-KLH-DC elicited comparable anti-tumor immune responses and inhibited tumor growth to the same extent. Combining radiotherapy with i.t. unpulsed-DC, KLH-DC or C-KLH-DC administration enhanced induction of anti-tumor immune responses and inhibition of tumor growth to a similar degree. Cryopreservation of KLH-DC slightly reduces viability, expression of co-stimulatory cell surface markers and in vitro function; however, in vivo anti-tumor activity is fully maintained with or without radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845485      PMCID: PMC2812438          DOI: 10.1016/j.clim.2008.08.022

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  42 in total

Review 1.  Keyhole limpet hemocyanin: molecular structure of a potent marine immunoactivator. A review.

Authors:  J R Harris; J Markl
Journal:  Eur Urol       Date:  2000       Impact factor: 20.096

2.  Freezing of dendritic cells, generated from cryopreserved leukaphereses, does not influence their ability to induce antigen-specific immune responses or functionally react to maturation stimuli.

Authors:  P Lewalle; R Rouas; F Lehmann; P Martiat
Journal:  J Immunol Methods       Date:  2000-06-23       Impact factor: 2.303

Review 3.  Keyhole limpet hemocyanin (KLH): a biomedical review.

Authors:  J R Harris; J Markl
Journal:  Micron       Date:  1999-12       Impact factor: 2.251

4.  Efficient cryopreservation of dendritic cells transfected with cDNA of a tumour antigen for clinical application.

Authors:  G Pecher; T Schirrmann; L Kaiser; J A Schenk
Journal:  Biotechnol Appl Biochem       Date:  2001-12       Impact factor: 2.431

5.  Immune and clinical responses in patients with metastatic melanoma to CD34(+) progenitor-derived dendritic cell vaccine.

Authors:  J Banchereau; A K Palucka; M Dhodapkar; S Burkeholder; N Taquet; A Rolland; S Taquet; S Coquery; K M Wittkowski; N Bhardwaj; L Pineiro; R Steinman; J Fay
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

Review 6.  In vitro production of dendritic cells from human blood monocytes for therapeutic use.

Authors:  L Garderet; H Cao; J Salamero; V Vergé; E Tisserand; S Scholl; N C Gorin; M Lopez
Journal:  J Hematother Stem Cell Res       Date:  2001-08

7.  A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use.

Authors:  B Feuerstein; T G Berger; C Maczek; C Röder; D Schreiner; U Hirsch; I Haendle; W Leisgang; A Glaser; O Kuss; T L Diepgen; G Schuler; B Schuler-Thurner
Journal:  J Immunol Methods       Date:  2000-11-01       Impact factor: 2.303

8.  Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells.

Authors:  K Schlienger; N Craighead; K P Lee; B L Levine; C H June
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

9.  Enhancement of tumor lysate- and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein.

Authors:  K Shimizu; E K Thomas; M Giedlin; J J Mulé
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

10.  Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.

Authors:  F J Hsu; C Benike; F Fagnoni; T M Liles; D Czerwinski; B Taidi; E G Engleman; R Levy
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

View more
  4 in total

1.  In vitro and in vivo antitumor effects of 50 to 100-KDa components from B16 melanoma culture supernatant.

Authors:  Ying-Song Qin; X U Zhang; Xiang-Yu Zhang
Journal:  Oncol Lett       Date:  2015-05-20       Impact factor: 2.967

2.  Hemocyanins Stimulate Innate Immunity by Inducing Different Temporal Patterns of Proinflammatory Cytokine Expression in Macrophages.

Authors:  Ta-Ying Zhong; Sergio Arancibia; Raimundo Born; Ricardo Tampe; Javiera Villar; Miguel Del Campo; Augusto Manubens; María Inés Becker
Journal:  J Immunol       Date:  2016-04-22       Impact factor: 5.422

3.  Radiotherapy combined with intratumoral dendritic cell vaccination enhances the therapeutic efficacy of adoptive T-cell transfer.

Authors:  Seagal Teitz-Tennenbaum; Qiao Li; Mary A Davis; Kari Wilder-Romans; Janet Hoff; Mu Li; Alfred E Chang
Journal:  J Immunother       Date:  2009 Jul-Aug       Impact factor: 4.456

4.  Mature dendritic cell derived from cryopreserved immature dendritic cell shows impaired homing ability and reduced anti-viral therapeutic effects.

Authors:  Qianqian Zhou; Yulong Zhang; Man Zhao; Xiaohui Wang; Cong Ma; Xinquan Jiang; Tao Wu; Donggen Wang; Linsheng Zhan
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.